ZD4522

New Drug Approvals by FDA & EMA (Mid-2020 Recap)

In case you thought Covid-19 had slowed down US Food and Drug Administration’s New Drug Approv

Analyzing over US$ 90 billion of Medicare Prescription Drug (Part D) Spending in 2016

This week, PharmaCompass reviews the recently released data on prescription drugs paid for under th

Pfizer exits China venture with Hisun; FDA mulls more steps to increase generic drug competition

This week in Phispers, we look at the measures US FDA announced last week to increase competition in

Trumpcare receives a blow; EMA to suspend 300 drugs due to clinical data integrity violations in India

This week, Phispers takes you to the US, where President Trump’s efforts to repeal and replace

The Next Generic Attack: Brilinta® (Ticagrelor), Xarelto® (Rivaroxaban), Tradjenta® (Linagliptin) and…

With almost 30,000 Drug Master Files (DMFs) submitted to the FDA, reviewing the filings of only the